Thursday, 28 March, 2024
Trending TopicsIpl 2024Lok Sabha 2024

---Advertisement---

AstraZeneca vaccine linked to 30% higher risk of blood clotting: Study; Here’s how to find out if you suffer from blood clots

New Delhi: AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. This was reported by news agency AFP. Thrombocytopenia syndrome is a possible side effect of vaccine Several countries have already altered their advice […]

Edited By : Mayank Kasyap | Updated: Oct 28, 2022 13:49 IST
Share :
Covishield Vaccine
Astrazeneca Vaccine (Representative Image)

New Delhi: AstraZeneca’s Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday. This was reported by news agency AFP.

Thrombocytopenia syndrome is a possible side effect of vaccine

Several countries have already altered their advice after previous research indicated that — in a tiny number of cases — thrombosis with thrombocytopenia syndrome (TTS) can be a possible side effect of Covid vaccines that use an adenovirus vector, or “engineered” virus, such as those from AstraZeneca and Johnson & Johnson.

TTS potentially causes life-threatening blood clots
Thrombocytopenia produces potentially life-threatening blood clots with low levels of blood platelets — the small cell fragments in our blood that prevent bleeding.

The new study, published in the British Medical Journal (BMJ), was the first to compare thrombocytopenia rates between adenovirus and mRNA vaccines — such as Pfizer — across multiple countries.

Research team analyzed the data of over 10 million adults

The international research team analyzed health data from more than 10 million adults in France, Germany, the Netherlands, Spain, the United Kingdom and the United States who received at least one vaccine dose between December 2020 and mid-2021.

In Germany and the UK, they matched the data of 1.3 million people who had a first dose of AstraZeneca to 2.1 million who took Pfizer.

There were a total of 862 “thrombocytopenia events” recorded in the 28 days after a first dose of AstraZeneca, compared to 520 for Pfizer, the study said.

That meant AstraZeneca’s vaccine had a 30-percent higher risk of thrombocytopenia than Pfizer.

Main outcome measures of the study

Thrombosis with thrombocytopenia syndrome or venous or arterial thromboembolic events within the 28 days after covid-19 vaccination. Incidence rate ratios were estimated after propensity scores matching and were calibrated using negative control outcomes. Estimates specific to the database were pooled by use of random effects meta-analyses.

Here’s how to find out if your blood is experiencing clots

D-dimer test

D-dimer tests are used to check for blood clotting problems. Blood clots can cause health problems, such as: Deep vein thrombosis (DVT) Disseminated intravascular coagulation (DIC) Pulmonary embolism (PE).

Having a high D-dimer level in your blood can be a sign of a blood clotting disorder. This happens because the level of D-dimer can rise greatly when there’s significant formation and breakdown of blood clots in your body.

First published on: Oct 28, 2022 01:34 PM IST

Get Breaking News First and Latest Updates from India and around the world on News24. Follow News24 on Facebook, Twitter.

Related Story